APA (7th ed.) Citation

Luporsi, P., Chopard, R., Janin, S., Racadot, E., Bernard, Y., Ecarnot, F., . . . Schiele, F. (2011). Use of recombinant factor VIIa (NovoSeven®®) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux. Acute Cardiac Care, 13(2), 93. https://doi.org/10.3109/17482941.2011.567281

Chicago Style (17th ed.) Citation

Luporsi, P., et al. "Use of Recombinant Factor VIIa (NovoSeven®®) in 8 Patients with Ongoing Life-threatening Bleeding Treated with Fondaparinux." Acute Cardiac Care 13, no. 2 (2011): 93. https://doi.org/10.3109/17482941.2011.567281.

MLA (9th ed.) Citation

Luporsi, P., et al. "Use of Recombinant Factor VIIa (NovoSeven®®) in 8 Patients with Ongoing Life-threatening Bleeding Treated with Fondaparinux." Acute Cardiac Care, vol. 13, no. 2, 2011, p. 93, https://doi.org/10.3109/17482941.2011.567281.